Rituximab-Associated Occurrence of Disseminated Miliary Tuberculosis

The increased utilization of immunosuppressive, antineoplastic agents in patients with hematologic malignancies and hematopoietic stem cell transplant recipients impairs humoral and cellular immunity. As a result, susceptibility to infectious diseases, including reactivation/development of tuberculosis and its dissemination to extrapulmonary sites, is a serious concern. Tuberculosis dissemination to extrapulmonary sites can mimic both clinical and radiological presentations of other etiologic agents. Thus, early diagnosis is often challenging. We present 3 cases of tuberculosis infection, of which 2 disseminated to extrapulmonary sites in patients with hematologic malignancies, along with literature review, clinical presentation, diagnostic evaluation, and differential diagnosis.

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Rituximab-Associated Occurrence of Disseminated Miliary Tuberculosis

Cited by 2 publications

References 5 publications

Pleural tuberculosis under rituximab therapy for anti-synthetase syndrome

Pleural tuberculosis under rituximab therapy for anti-synthetase syndrome

Reactivation and Dissemination of Tuberculosis to Extrapulmonary Sites in Patients With Hematologic Malignancies

Contact Info

Product

Resources

About